Tag: intraocular pressure
May 17, 2017
Aldeyra Therapeutics Reveals Results from ADX-102 Trial
Aldeyra Therapeutics presented the results from their Phase 2 clinical trial of ADX-102 at this years' meeting of the Association... May 10, 2017
InMed Files Patent for Cannabinoid-Based Glaucoma Treatment
InMed Pharmaceuticals has filed to apply for a provisional patent in the US related to INM-085 as a cannabinoid-based topical... May 9, 2017
pSivida Reveals Follow-Up Data on Durasert Trial
pSivida announced positive data from a 12-month follow-up on the company's three-year treatment for posterior segment uveitis. April 27, 2017
Aldeyra Gets First Patient Enrolled in Phase 3 Trial
Aldeyra Therapeutics enrolled the first patient in their Phase 3 clinical trial of ADX-102.
April 25, 2017
Q BioMed Announces Licensing Agreement for Development of Drug to Treat Rare Pediatric Disorder
Q BioMed Inc. (OTCQB: QBIO) and ASDERA LLC today announce a licensing agreement that provides Q BioMed with the worldwide... February 22, 2017
Alimera Sciences and Knight Therapeutics Announce Filing of New Drug Submission for Iluvien® in Canada
Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in research, development and commercialization of prescription ophthalmic pharmaceuticals, and Knight Therapeutics Inc.... January 25, 2017